Copyright Reports & Markets. All rights reserved.

Global Biobetter Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Biobetter Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 G-CSF Biobetters
    • 1.3.3 Insulin Biobetters
    • 1.3.4 Erythropoietin Biobetters
    • 1.3.5 Monoclonal Antibodies Biobetters
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Biobetter Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cancer
    • 1.4.3 Diabetes
    • 1.4.4 Genetic Disease
    • 1.4.5 Neurological Disorders
    • 1.4.6 Others
  • 1.5 Global Biobetter Market Size & Forecast
    • 1.5.1 Global Biobetter Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Biobetter Sales Quantity (2021-2032)
    • 1.5.3 Global Biobetter Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 F.Hoffmann-La Roche AG
    • 2.1.1 F.Hoffmann-La Roche AG Details
    • 2.1.2 F.Hoffmann-La Roche AG Major Business
    • 2.1.3 F.Hoffmann-La Roche AG Biobetter Product and Services
    • 2.1.4 F.Hoffmann-La Roche AG Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 F.Hoffmann-La Roche AG Recent Developments/Updates
  • 2.2 Merck and Co.
    • 2.2.1 Merck and Co. Details
    • 2.2.2 Merck and Co. Major Business
    • 2.2.3 Merck and Co. Biobetter Product and Services
    • 2.2.4 Merck and Co. Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck and Co. Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Biobetter Product and Services
    • 2.3.4 Sanofi Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 SERVIER
    • 2.4.1 SERVIER Details
    • 2.4.2 SERVIER Major Business
    • 2.4.3 SERVIER Biobetter Product and Services
    • 2.4.4 SERVIER Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 SERVIER Recent Developments/Updates
  • 2.5 Porton Biopharma
    • 2.5.1 Porton Biopharma Details
    • 2.5.2 Porton Biopharma Major Business
    • 2.5.3 Porton Biopharma Biobetter Product and Services
    • 2.5.4 Porton Biopharma Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Porton Biopharma Recent Developments/Updates
  • 2.6 Eli Lily and Company
    • 2.6.1 Eli Lily and Company Details
    • 2.6.2 Eli Lily and Company Major Business
    • 2.6.3 Eli Lily and Company Biobetter Product and Services
    • 2.6.4 Eli Lily and Company Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Eli Lily and Company Recent Developments/Updates
  • 2.7 Novo Nordisk
    • 2.7.1 Novo Nordisk Details
    • 2.7.2 Novo Nordisk Major Business
    • 2.7.3 Novo Nordisk Biobetter Product and Services
    • 2.7.4 Novo Nordisk Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Novo Nordisk Recent Developments/Updates
  • 2.8 Biogen
    • 2.8.1 Biogen Details
    • 2.8.2 Biogen Major Business
    • 2.8.3 Biogen Biobetter Product and Services
    • 2.8.4 Biogen Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Biogen Recent Developments/Updates
  • 2.9 CSL Behring GmbH
    • 2.9.1 CSL Behring GmbH Details
    • 2.9.2 CSL Behring GmbH Major Business
    • 2.9.3 CSL Behring GmbH Biobetter Product and Services
    • 2.9.4 CSL Behring GmbH Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CSL Behring GmbH Recent Developments/Updates
  • 2.10 Teva
    • 2.10.1 Teva Details
    • 2.10.2 Teva Major Business
    • 2.10.3 Teva Biobetter Product and Services
    • 2.10.4 Teva Biobetter Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Teva Recent Developments/Updates

3 Competitive Environment: Biobetter by Manufacturer

  • 3.1 Global Biobetter Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Biobetter Revenue by Manufacturer (2021-2026)
  • 3.3 Global Biobetter Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Biobetter by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Biobetter Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Biobetter Manufacturer Market Share in 2025
  • 3.5 Biobetter Market: Overall Company Footprint Analysis
    • 3.5.1 Biobetter Market: Region Footprint
    • 3.5.2 Biobetter Market: Company Product Type Footprint
    • 3.5.3 Biobetter Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Biobetter Market Size by Region
    • 4.1.1 Global Biobetter Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Biobetter Consumption Value by Region (2021-2032)
    • 4.1.3 Global Biobetter Average Price by Region (2021-2032)
  • 4.2 North America Biobetter Consumption Value (2021-2032)
  • 4.3 Europe Biobetter Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Biobetter Consumption Value (2021-2032)
  • 4.5 South America Biobetter Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Biobetter Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Biobetter Sales Quantity by Type (2021-2032)
  • 5.2 Global Biobetter Consumption Value by Type (2021-2032)
  • 5.3 Global Biobetter Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Biobetter Sales Quantity by Application (2021-2032)
  • 6.2 Global Biobetter Consumption Value by Application (2021-2032)
  • 6.3 Global Biobetter Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Biobetter Sales Quantity by Type (2021-2032)
  • 7.2 North America Biobetter Sales Quantity by Application (2021-2032)
  • 7.3 North America Biobetter Market Size by Country
    • 7.3.1 North America Biobetter Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Biobetter Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Biobetter Sales Quantity by Type (2021-2032)
  • 8.2 Europe Biobetter Sales Quantity by Application (2021-2032)
  • 8.3 Europe Biobetter Market Size by Country
    • 8.3.1 Europe Biobetter Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Biobetter Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Biobetter Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Biobetter Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Biobetter Market Size by Region
    • 9.3.1 Asia-Pacific Biobetter Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Biobetter Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Biobetter Sales Quantity by Type (2021-2032)
  • 10.2 South America Biobetter Sales Quantity by Application (2021-2032)
  • 10.3 South America Biobetter Market Size by Country
    • 10.3.1 South America Biobetter Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Biobetter Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Biobetter Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Biobetter Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Biobetter Market Size by Country
    • 11.3.1 Middle East & Africa Biobetter Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Biobetter Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Biobetter Market Drivers
  • 12.2 Biobetter Market Restraints
  • 12.3 Biobetter Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Biobetter and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Biobetter
  • 13.3 Biobetter Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Biobetter Typical Distributors
  • 14.3 Biobetter Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Biobetter market size was valued at US$ 1098 million in 2025 and is forecast to a readjusted size of US$ 1981 million by 2032 with a CAGR of 8.9% during review period.
    Biobetters, also known as biosuperiors, are recombinant protein drugs from an identical class as a present set of biopharmaceuticals is not similar to the source. It is neither a wholly novel medicine nor a generic version of an old drug. It is a biological product designed to increase clinical efficacy while also improving tolerance and lowering dosing/administration frequency.
    According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
    This report is a detailed and comprehensive analysis for global Biobetter market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Biobetter market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Biobetter market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Biobetter market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Biobetter market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Biobetter
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Biobetter market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen, CSL Behring GmbH, Teva, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Biobetter market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    G-CSF Biobetters
    Insulin Biobetters
    Erythropoietin Biobetters
    Monoclonal Antibodies Biobetters
    Others
    Market segment by Application
    Cancer
    Diabetes
    Genetic Disease
    Neurological Disorders
    Others
    Major players covered
    F.Hoffmann-La Roche AG
    Merck and Co.
    Sanofi
    SERVIER
    Porton Biopharma
    Eli Lily and Company
    Novo Nordisk
    Biogen
    CSL Behring GmbH
    Teva
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Biobetter product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Biobetter, with price, sales quantity, revenue, and global market share of Biobetter from 2021 to 2026.
    Chapter 3, the Biobetter competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Biobetter breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Biobetter market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Biobetter.
    Chapter 14 and 15, to describe Biobetter sales channel, distributors, customers, research findings and conclusion.

    Buy now